RIFAMPIN — all Canadian products
6 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is RIFAMPIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00343617 | ROFACT | BAUSCH HEALTH, CANADA INC. | Capsule | Oral | RIFAMPIN 300 MG | Marketed | |
| 00393444 | ROFACT | BAUSCH HEALTH, CANADA INC. | Capsule | Oral | RIFAMPIN 150 MG | Marketed | |
| 02091887 | RIFADIN | SANOFI-AVENTIS CANADA INC | Capsule | Oral | RIFAMPIN 150 MG | Cancelled Post Market | |
| 02092808 | RIFADIN | SANOFI-AVENTIS CANADA INC | Capsule | Oral | RIFAMPIN 300 MG | Cancelled Post Market | |
| 00580384 | RIFADIN CAP 300MG | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | Capsule | Oral | RIFAMPIN 300 MG | Cancelled Post Market | |
| 02148625 | RIFATER | SANOFI-AVENTIS CANADA INC | Tablet | Oral | RIFAMPIN 120 MG; ISONIAZID 50 MG; PYRAZINAMIDE 300 MG | Cancelled Post Market |
Browse other molecules: